Chromosomal Instability: Clinical Trials

9 trials for Chromosomal Instability, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 2 recruiting, 1 withdrawn. 2 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Not applicable1Withdrawn 1
Phase 21Recruiting 1

Follow Chromosomal Instability: new trials by email Literature Review of Chromosomal Instability trials Research Report on Chromosomal Instability

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
Endometrial Neoplasms, TP53 Gene Mutation
UnknownPeking Union Medical College Hospital1102024-09-012024-07-26
A Study of Sovilnesib in Subjects With Ovarian Cancer
Sovilnesib - High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer
Phase 1RecruitingVolastra Therapeutics, Inc.1502024-04-042026-10-13
Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup
urine sample collection - Bladder Cancer
UnknownChanghai Hospital1002023-12-012023-12-01
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
VLS-1488 - Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary
Phase 1 / Phase 2RecruitingVolastra Therapeutics, Inc.2002023-10-182025-11-04
Application of Chromosomal Instability in Early Diagnosis of Biliary Tract Carcinoma
The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN. - Biliary Tract Carcinoma
UnknownTaizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University3002023-03-302023-12-18
Chromosomal Instability in Ovarian Cancer
Testing for chromosomal instability (CIN) - Epithelial Ovarian Cancer, High-grade Serous Ovarian Carcinoma
UnknownLei Li3002022-03-262022-04-04
Evaluation of Ultrasensitive Chromosomal Aneuploidy Detection for Detecting Minimal Residual Disease in Multiple Myeloma
The level of plasma cfDNA CINs - Multiple Myeloma
UnknownShanghai Changzheng Hospital1002019-10-202019-11-18
Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
Colorectal Neoplasms
UnknownRadboud University Medical Center1302004-03-012007-03-01
Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study
surgery, follow up - Chromosomal Instability, Low Grade Dysplasia Oral Cavity
Not applicableWithdrawnMaastricht University Medical Center2018-01-09

Narrower conditions

Endometrial Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colorectal Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Microsatellite Instability (1)  ·  Multiple Myeloma (1)  ·  Neoplasm, Residual (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Chromosome Aberrations (9)  ·  Genomic Instability (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Neoplasms (7)  ·  Neoplasms by Site (6)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Urogenital Diseases (5)  ·  Urogenital Neoplasms (5)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  Neoplasms by Histologic Type (3)  ·  Adnexal Diseases (2)

Interventions

Surgical Procedures, Operative (1)

Sponsors

Volastra Therapeutics, Inc. (2)  ·  Changhai Hospital (1)  ·  Lei Li (1)  ·  Maastricht University Medical Center (1)  ·  Peking Union Medical College Hospital (1)  ·  Radboud University Medical Center (1)  ·  Shanghai Changzheng Hospital (1)  ·  Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University (1)

Countries

China (4)  ·  Netherlands (2)  ·  United States (2)

Top investigators

Lei Li, M.D. (1)  ·  Maarten Borgemeester, MD (1)  ·  Nicoline Hoogerbrugge, MD, PhD (1)

Results publications

PMID 16765182, PMID 26718401